Point72 Hong Kong’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$307K Buy
+669
New +$250K 0.01% 287
2021
Q4
Sell
-932
Closed -$74K 2181
2021
Q3
$74K Sell
932
-513
-36% -$44.3K ﹤0.01% 1426
2021
Q2
$141K Buy
+1,445
New +$171K ﹤0.01% 1237
2021
Q1
Sell
-246
Closed -$27K 2054
2020
Q4
$27K Buy
+246
New +$30.1K ﹤0.01% 1363
2020
Q3
Sell
-86
Closed -$10K 1388
2020
Q2
$10K Buy
+86
New +$8.46K ﹤0.01% 981
2020
Q1
Sell
-36
Closed -$3K 1183
2019
Q4
$3K Buy
+36
New +$3.49K ﹤0.01% 1066

Other funds holding MDGL

Point72 Hong Kong's MDGL Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2025: 669 shares worth $307K. The stake represents 0.01% of the portfolio and ranks #287 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in MDGL as recently as Q3 2021.

Point72 Hong Kong first reported a position in MDGL in Q4 2019 and has held it in 6 quarters since. 352 funds tracked by Wall St. Rank hold MDGL as of Q3 2025.

  • Point72 Hong Kong held 669 shares of Madrigal Pharmaceuticals worth $307K as of Q3 2025.
  • Madrigal Pharmaceuticals was a new Point72 Hong Kong position in Q3 2025.
  • Madrigal Pharmaceuticals made up 0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #287 holding.
  • Point72 Hong Kong first reported a position in Madrigal Pharmaceuticals in Q4 2019 and has held it in 6 quarters since.
  • 352 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.